These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 25877442

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparison of pharmacokinetics of two fenofibrate tablet formulations in healthy human subjects.
    Chachad SS, Gole M, Malhotra G, Naidu R.
    Clin Ther; 2014 Jun 01; 36(6):967-73. PubMed ID: 24844853
    [Abstract] [Full Text] [Related]

  • 6. Randomised crossover studies of the bioequivalence of two fenofibrate formulations after administration of a single oral dose in healthy volunteers.
    Sonet B, Vanderbist F, Streel B, Houin G.
    Arzneimittelforschung; 2002 Jun 01; 52(3):200-4. PubMed ID: 11963648
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics and comparative bioavailability of two fenofibrate capsule formulations in healthy volunteers.
    Vlase L, Popa A, Muntean D, Leucuta SE.
    Arzneimittelforschung; 2010 Jun 01; 60(9):560-3. PubMed ID: 21117499
    [Abstract] [Full Text] [Related]

  • 8. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C, Bujanover S, Kareht S, Rapoport AM.
    Headache; 2015 Feb 01; 55(2):265-75. PubMed ID: 25546369
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The effects of food on the bioavailability of fenofibrate administered orally in healthy volunteers via sustained-release capsule.
    Yun HY, Joo Lee E, Youn Chung S, Choi SO, Kee Kim H, Kwon JT, Kang W, Kwon KI.
    Clin Pharmacokinet; 2006 Feb 01; 45(4):425-32. PubMed ID: 16584288
    [Abstract] [Full Text] [Related]

  • 13. Bioequivalence study of two limaprost alfadex 5 microg tablets in healthy subjects: moisture-resistant tablet (dextran formulation) versus standard tablet (lactose formulation).
    Nakade S, Komaba J, Ohno T, Kitagawa J, Furukawa K, Miyata Y.
    Int J Clin Pharmacol Ther; 2008 Jan 01; 46(1):42-7. PubMed ID: 18218297
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Differences in bioavailability between 60 mg of nifedipine osmotic push-pull systems after fasted and fed administration.
    Anschütz M, Wonnemann M, Schug B, Toal C, Donath F, Pontius A, Pauli K, Brendel E, Blume H.
    Int J Clin Pharmacol Ther; 2010 Feb 01; 48(2):158-70. PubMed ID: 20137768
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Bioavailability of oxycodone after administration of a new prolonged-release once-daily tablet formulation in healthy subjects, in comparison to an established twice-daily tablet
.
    Scheidel B, Maritz MA, Gschwind YJ, Steigerwald K, Guth V, Kovacs P, Rey H.
    Int J Clin Pharmacol Ther; 2017 Nov 01; 55(11):881-890. PubMed ID: 28933336
    [Abstract] [Full Text] [Related]

  • 19. Bioavailability and Pharmacokinetics of TRPV1 Antagonist Mavatrep (JNJ-39439335) Tablet and Capsule Formulations in Healthy Men: Two Open-Label, Crossover, Single-Dose Phase 1 Studies.
    Manitpisitkul P, Shalayda K, Russell L, Sanga P, Williams Y, Solanki B, Caruso J, Moyer JA.
    Clin Pharmacol Drug Dev; 2018 Sep 01; 7(7):699-711. PubMed ID: 29125700
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.